Mark Blostein Selected Research

Mark Blostein Research Topics

7	Atrial Fibrillation 01/2021 - 01/2013
6	Hemorrhage 01/2021 - 07/2013
3	Neoplasms (Cancer) 09/2012 - 05/2007
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 09/2020
2	Thromboembolism 01/2021 - 11/2019
2	Thrombosis (Thrombus) 01/2021 - 09/2020
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 01/2020
2	Venous Thromboembolism 02/2014 - 07/2007
2	Thrombophilia 07/2007 - 01/2007
2	Urogenital Neoplasms 06/2007 - 05/2007
2	Thrombophlebitis 01/2007 - 08/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Pulmonary Embolism 09/2020
1	Chest Pain (Chest Pains) 09/2020
1	Vertigo (Positional Vertigo) 09/2020
1	Pancreatitis 09/2020
1	Embolism (Embolus) 11/2019
1	Transient Ischemic Attack 11/2019
1	Ischemic Stroke 11/2019
1	Thrombocytopenia (Thrombopenia) 11/2011
1	Pregnancy Complications 07/2007
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2007
1	Prostatic Neoplasms (Prostate Cancer) 05/2007
1	Sepsis (Septicemia) 08/2002
1	Catheter-Related Infections 08/2002

7	AnticoagulantsIBA 01/2021 - 06/2007
5	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 05/2007
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 06/2007
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 11/2011
3	RivaroxabanIBA 01/2020 - 11/2019
2	eltrombopag FDA Link 01/2022 - 09/2020
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2021 - 07/2007
2	Dabigatran FDA Link 11/2019 - 07/2015
2	CreatinineIBA 11/2019 - 07/2015
1	Inosine Triphosphate (ITP)IBA 01/2022
1	apixabanIBA 11/2019
1	Heparin (Liquaemin)FDA LinkGeneric 11/2019
1	Abciximab (ReoPro)FDA Link 11/2011
1	coumarinIBA 06/2007
1	Prescription DrugsIBA 05/2007

3	Catheters 01/2021 - 08/2002
2	Therapeutics 11/2019 - 11/2011
1	Splenectomy 09/2020
1	Minor Surgical Procedures (Minor Surgery) 09/2020